← Leaderboards
Malcolm S Duthie
Hdt Bio Corporation
$710,328
Attributed
$710,328
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $489.1K · FY2020–21$500K$375K$250K$125K$0
'20
'21
Funding mix
By agency
NIH$710,328 · 2
By mechanism
R21$486,691 · 1
R43$223,637 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Immune”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,310,675
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ted Ross · University Of Georgia$74,507,826
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Tony Moody · Duke University$66,767,417
Research focus
ImmunePublic HealthAntibodiesInfectionDoseAntigensProgramsReportingEnsureClinical DevelopmentDisabilityAnti-Leprosy VaccineBiological MarkersEnzyme-Linked Immunosorbent AssayDermatologicCytokineDetectionCase StudyCountryChargeChimeric ProteinsChronic DiseaseCandidate MarkerBrazil
Grant awards (3)
Assessing immunogenicity of LepVax: a new leprosy vaccine in clinical development$265,468
R21 · FY2021 · AI · contact PI
Development of CoroDetecT, a skin test for SARS-CoV-2 infection$223,637
R43 · FY2021 · AI · contact PI
Assessing immunogenicity of LepVax: a new leprosy vaccine in clinical development$221,223
R21 · FY2020 · AI · contact PI